vs
ACRES Commercial Realty Corp.(ACR)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
ACRES Commercial Realty Corp.的季度营收约是SUTRO BIOPHARMA, INC.的1.7倍($20.0M vs $11.6M),ACRES Commercial Realty Corp.同比增速更快(-6.5% vs -21.4%),过去两年ACRES Commercial Realty Corp.的营收复合增速更高(3.3% vs -5.4%)
皮拉马尔地产是一家印度房地产企业,2012年成立,总部位于印度孟买,隶属于皮拉马尔集团。公司专注于住宅及商业地产开发,目前在手开发项目总规模约达1500万平方英尺,知名项目包括Piramal Aranya、Piramal Mahalaxmi等。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
ACR vs STRO — 直观对比
营收规模更大
ACR
是对方的1.7倍
$11.6M
营收增速更快
ACR
高出14.8%
-21.4%
两年增速更快
ACR
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.0M | $11.6M |
| 净利润 | $6.3M | — |
| 毛利率 | — | — |
| 营业利润率 | 30.8% | — |
| 净利率 | 31.6% | — |
| 营收同比 | -6.5% | -21.4% |
| 净利润同比 | -32.0% | 35.4% |
| 每股收益(稀释后) | $-0.41 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACR
STRO
| Q4 25 | $20.0M | $11.6M | ||
| Q3 25 | $21.0M | $9.7M | ||
| Q2 25 | $21.9M | $63.7M | ||
| Q1 25 | $17.0M | $17.4M | ||
| Q4 24 | $21.4M | $14.8M | ||
| Q3 24 | $22.4M | $8.5M | ||
| Q2 24 | $20.9M | $25.7M | ||
| Q1 24 | $18.8M | $13.0M |
净利润
ACR
STRO
| Q4 25 | $6.3M | — | ||
| Q3 25 | $18.0M | $-56.9M | ||
| Q2 25 | $4.3M | $-11.5M | ||
| Q1 25 | $-730.0K | $-76.0M | ||
| Q4 24 | $9.3M | $-72.4M | ||
| Q3 24 | $8.1M | $-48.8M | ||
| Q2 24 | $6.4M | $-48.0M | ||
| Q1 24 | $4.9M | $-58.2M |
营业利润率
ACR
STRO
| Q4 25 | 30.8% | — | ||
| Q3 25 | 85.8% | -499.9% | ||
| Q2 25 | 19.8% | -5.2% | ||
| Q1 25 | -3.8% | -393.8% | ||
| Q4 24 | 43.4% | -440.7% | ||
| Q3 24 | 36.4% | -797.2% | ||
| Q2 24 | 30.8% | -189.4% | ||
| Q1 24 | 26.2% | -435.0% |
净利率
ACR
STRO
| Q4 25 | 31.6% | — | ||
| Q3 25 | 85.8% | -586.6% | ||
| Q2 25 | 19.8% | -18.0% | ||
| Q1 25 | -4.3% | -436.6% | ||
| Q4 24 | 43.5% | -489.2% | ||
| Q3 24 | 36.0% | -572.6% | ||
| Q2 24 | 30.6% | -186.8% | ||
| Q1 24 | 26.2% | -447.5% |
每股收益(稀释后)
ACR
STRO
| Q4 25 | $-0.41 | — | ||
| Q3 25 | $1.34 | $-0.67 | ||
| Q2 25 | $-0.10 | $-0.14 | ||
| Q1 25 | $-0.80 | $-0.91 | ||
| Q4 24 | $0.51 | $-27.63 | ||
| Q3 24 | $0.36 | $-0.59 | ||
| Q2 24 | $0.21 | $-0.59 | ||
| Q1 24 | $0.07 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $83.8M | $141.4M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $420.8M | $-132.5M |
| 总资产 | $2.2B | $173.8M |
| 负债/权益比越低杠杆越低 | 3.68× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACR
STRO
| Q4 25 | $83.8M | $141.4M | ||
| Q3 25 | $40.9M | $167.6M | ||
| Q2 25 | $42.7M | $205.1M | ||
| Q1 25 | $66.0M | $249.0M | ||
| Q4 24 | $56.7M | $316.9M | ||
| Q3 24 | $70.1M | $388.3M | ||
| Q2 24 | $89.6M | $375.6M | ||
| Q1 24 | $84.6M | $267.6M |
总债务
ACR
STRO
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
股东权益
ACR
STRO
| Q4 25 | $420.8M | $-132.5M | ||
| Q3 25 | $432.9M | $-87.3M | ||
| Q2 25 | $425.3M | $-32.1M | ||
| Q1 25 | $430.1M | $-25.8M | ||
| Q4 24 | $439.1M | $44.6M | ||
| Q3 24 | $436.3M | $111.2M | ||
| Q2 24 | $434.0M | $152.2M | ||
| Q1 24 | $432.8M | $98.0M |
总资产
ACR
STRO
| Q4 25 | $2.2B | $173.8M | ||
| Q3 25 | $1.7B | $209.7M | ||
| Q2 25 | $1.8B | $262.4M | ||
| Q1 25 | $1.8B | $321.4M | ||
| Q4 24 | $1.9B | $387.2M | ||
| Q3 24 | $2.0B | $451.8M | ||
| Q2 24 | $2.1B | $489.0M | ||
| Q1 24 | $2.1B | $403.4M |
负债/权益比
ACR
STRO
| Q4 25 | 3.68× | — | ||
| Q3 25 | 2.76× | — | ||
| Q2 25 | 3.10× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 3.12× | — | ||
| Q3 24 | 3.43× | — | ||
| Q2 24 | 3.67× | — | ||
| Q1 24 | 3.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.1M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.65× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ACR
STRO
| Q4 25 | $4.1M | $-177.2M | ||
| Q3 25 | $-9.4M | $-38.2M | ||
| Q2 25 | $11.8M | $-44.7M | ||
| Q1 25 | $-4.6M | $-67.9M | ||
| Q4 24 | $19.4M | $-71.7M | ||
| Q3 24 | $8.4M | $-64.5M | ||
| Q2 24 | $6.9M | $9.5M | ||
| Q1 24 | $3.3M | $-64.7M |
现金转化率
ACR
STRO
| Q4 25 | 0.65× | — | ||
| Q3 25 | -0.52× | — | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACR
| Other | $10.8M | 54% |
| Pacmulti JVLLC | $5.2M | 26% |
| Mccallum Jv Llc | $2.5M | 12% |
| Office Complex | $1.5M | 7% |
STRO
暂无分部数据